THE PATIENT WE BUILT THIS FOR.
Surgical recovery is a clinical category that has been quietly underserved. The patient finishes their post-op visits, hits a plateau, and starts asking what else is possible. The answers they find online come from biohackers, bodybuilders, and research-chemical vendors selling unregulated compounds with no physician in the loop. Those answers are not safe. They are also not nothing — they reflect a real demand that academic medicine has been slow to address. Truthe Ortho is what happens when surgeons take that demand seriously and answer it inside the standards of clinical medicine instead of outside them.
WHAT WE BELIEVE ABOUT EVIDENCE.
Three principles guide how we evaluate and communicate the science behind every compound we prescribe.
Honesty about evidence beats marketing about evidence.
We grade every compound we use against the same rubric — Human Clinical Trials, Strong Preclinical, Early Research — and we publish the grade next to the compound. When the evidence is preclinical only, we say so. When the evidence comes disproportionately from a single research group, we name it. The competitors who hide these gaps are precisely what regulators will measure us against.
Mechanism is necessary but not sufficient.
A compelling mechanistic rationale is the start of an evidence case, not the end of one. We exclude compounds whose mechanism conflicts with post-surgical physiology even when bro-science forums are enthusiastic about them. We include compounds whose mechanism aligns with the surgical question even when the human data is still maturing — and we say which is which.
We are building the evidence we wish existed.
Every Truthe Ortho patient generates follow-up data: lab checkpoints, clinical check-ins, adverse-event documentation. Within twelve months of launch we intend to publish the first real-world outcomes report for peptide-supported surgical recovery. Real patients, real surgeries, transparent methodology.
WHAT WE BELIEVE ABOUT SUPERVISION.
The physician is not optional. Every element of our model is structured around that constraint.
Peptides without a physician is the problem we're solving.
Our entire model is structured around the prescribing physician, the compounding pharmacy, and the monitoring care team. There is no version of Truthe Ortho that ships a vial without clinical context, no scenario in which a patient self-prescribes from a menu, no path that bypasses the partner surgeon.
Procedure-specific, not category-specific.
ACL reconstruction is not rotator cuff repair is not spinal fusion is not abdominoplasty. Recovery physiology, anticoagulation status, surgical site characteristics, and rehabilitation timelines diverge sharply between procedures. Our protocols reflect that. We do not sell stacks.
Coordination, not competition, with the partner surgeon.
The surgeon who performed the operation is the most important physician on the recovery team. We coordinate with their office on protocol design, share progress reports back, and never recommend anything that conflicts with their post-op care plan. Two physicians, one patient, aligned care.
WHAT WE WILL NOT DO.
- ●
We will not include compounds whose mechanism contradicts post-surgical physiology — appetite stimulants in bariatric protocols, cortisol elevators in tissue-healing protocols, GH-axis compounds with documented critical-illness mortality signals.
- ●
We will not market peptides for indications they do not support. Structure-and-function language is not a loophole we exploit; it is a constraint we accept.
- ●
We will not source from research-chemical vendors, label-flexible "wellness" suppliers, or any pharmacy that cannot document FDA registration and cGMP compliance.
- ●
We will not pay or receive per-referral compensation. Partner physicians are compensated for services rendered — advisory work, protocol review, education — at fair market value, documented and defensible.
- ●
We will not hide adverse events. Every event is documented, reviewed, and reported within 24 hours to the partner surgeon. Quarterly safety reviews are formal and minuted.
HOW WE MEASURE OURSELVES.
We hold ourselves to the standards of academic medicine even though we operate as a private practice. Baseline and follow-up labs on every protocol. Scheduled clinical check-ins. A formal pharmacovigilance pipeline. Annual insurance re-underwriting against actual claim experience. The evidence base for peptide-supported surgical recovery will only grow if someone is willing to generate it under real conditions and publish what it says — including the parts that are inconvenient.
Clinical-grade peptides, designed by surgeons, built for patients who want evidence over hype.
— Chad M. Ferguson, MD